Flortaucipir F18 (Tauvid) Radioactive Tracer for Positron Emission Tomography (PET)/ Computed Tomography (CT) Imaging
ID: A042616Type: Sources Sought
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE AIR FORCEFA8601 AFLCMC PZIOWRIGHT PATTERSON AFB, OH, 45433-5344, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/4c6ff264163a46e08ecd67b976647cca/view
Timeline
    Description

    The Department of Defense, through the Air Force Life Cycle Management Center (AFLCMC) at Wright-Patterson Air Force Base, is seeking capabilities packages from potential sources for the Flortaucipir F18 (Tauvid) radioactive tracer, intended for use in Positron Emission Tomography (PET) and Computed Tomography (CT) imaging. This procurement aims to establish a five-year Blanket Purchase Agreement (BPA) to ensure rapid access to this critical imaging agent, which is essential for detecting tau neurofibrillary tangles, significant markers of Alzheimer’s disease. Vendors must comply with FDA regulations, provide secure delivery access to the base, and adhere to safety protocols for handling radioactive materials. Interested firms are required to submit their capabilities packages by October 14, 2024, to the primary contact, Mr. Curtis Thomas, at curtis.thomas.4@us.af.mil, with a copy to Amanda Hoyng at amanda.hoyng@us.af.mil.

    Point(s) of Contact
    Curtis Thomas
    curtis.thomas.4@us.af.mil
    Amanda Hoyng
    amanda.hoyng@us.af.mil
    Files
    Title
    Posted
    ATTACHMENT 1 - Instructions_Sources Sought_Tauvid.pdf
    The document outlines a sources sought notice for the Flortaucipir F18 (Tauvid) radioactive tracer, intended for use in Positron Emission Tomography (PET) and Computed Tomography (CT) imaging. The Air Force is soliciting information from potential vendors regarding their capabilities to provide this product, emphasizing the need for specific details such as company ownership, socio-economic status, manufacturing data, warranty information, and past sales history. The request highlights the possibility of a small business set-aside, contingent upon verification of interest and capability among small businesses. Respondents are urged to address their compliance with Federal Acquisition Regulation (FAR) guidelines and to consider potential subcontracting opportunities if applicable. The document also requests information about manufacturing locations, company experience with similar projects, and any barriers to fulfilling the requirements specified. Overall, the notice seeks to gather comprehensive responses from potential suppliers to inform future procurement decisions related to this specialized tracer.
    Sources Sought_SAM_Tauvid.pdf
    The United States Air Force, specifically the Air Force Life Cycle Management Center (AFLCMC) at Wright-Patterson Air Force Base, is conducting a Sources Sought inquiry to identify capable manufacturers of the Flortaucipir F18 (Tauvid) radioactive tracer for Positron Emission Tomography (PET) and Computed Tomography (CT) imaging. This inquiry seeks responses from a range of businesses, particularly small businesses and those qualifying under specific socio-economic categories. Interested firms are invited to submit capabilities packages that detail their ability to meet the provided technical requirements, adhering to specifications outlined in the document. The inquiry serves purely for market research rather than soliciting proposals, and responses are due by October 14, 2024. Participation requires respondents to be registered in the SAM database, and the document outlines submission guidelines to ensure compliance with email filters. A potential small business set-aside may be considered based on the responses received. Overall, this effort aims to establish a viable source for the required radioactive tracer, supporting the medical treatment facility's imaging needs at the Air Force base.
    SOW _TAUVID_26 September 2024_Sources Sought.pdf
    The 88th Medical Treatment Facility (MTF) at Wright-Patterson AFB, OH, seeks a five-year Blanket Purchase Agreement (BPA) for Flortaucipir F18 (Tauvid), a radioactive tracer used in PET imaging to detect tau neurofibrillary tangles, significant markers of Alzheimer’s disease. This procurement aims to enable rapid access to necessary examinations. Vendors must comply with FDA approvals, secure base access for deliveries, provide orders in specified syringe doses, and implement safe handling protocols of radioactive materials. Key responsibilities include waste management of tracer packages and adherence to safety and regulatory compliance standards. Regular reviews of procedures will ensure optimally safe and efficient use of Tauvid within the realms of diagnosis and Alzheimer’s disease research. This statement details the operational framework for utilizing this imaging agent in enhancing patient management and advancing academic understanding of Alzheimer's disease.
    Similar Opportunities
    6550--VA Northern California Health Care System, Mather Radiopharmaceuticals & Radiopharmaceutical Supplies
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the provision of radiopharmaceuticals and related supplies for the VA Northern California Health Care System, with a contract period spanning from April 1, 2025, to March 31, 2030. The procurement includes the delivery of various diagnostic and therapeutic radiopharmaceuticals, which are critical for effective healthcare services, particularly for veterans requiring advanced medical treatments. Contractors must comply with regulatory standards from the Nuclear Regulatory Commission and the Food and Drug Administration, ensuring quality control and timely delivery, especially for emergency services, with a minimum guaranteed contract value of $100 and a maximum of $2.5 million for total orders. Interested parties should submit their questions in writing by October 14, 2024, and direct their inquiries to Contract Specialist Tawnya S Krommenhoek at tawnya.krommenhoek@va.gov.
    6505--Ga68 PSMA Injection (Illucix)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking a contractor to provide Gallium Ga68 (Ga68-PSMA; Illucix®) radiopharmaceutical injections for the VA North Texas Health Care System, with a focus on PET imaging of prostate cancer lesions. The procurement requires contractors to possess a valid license from the US Nuclear Regulatory Commission and adhere to federal and state regulations regarding the handling and transportation of radioactive materials, ensuring safe and efficient delivery of essential medical supplies. Interested parties must submit their quotations by October 8, 2024, at 3:00 PM CST, to the designated Contract Specialist, Vance Farrell, via email, with the anticipated delivery period set from October 25, 2024, to October 24, 2025.
    6505--PYLARIFY (F18 Piflufolastat)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, through the Network Contracting Office 17, intends to award a sole-source procurement for PYLARIFY® (Piflufolastat F18 Injection) from Progenics Pharmaceuticals. The procurement involves the acquisition of 500 units of this pharmaceutical product, which is critical for the agency's healthcare services. Progenics Pharmaceuticals has confirmed that it is the sole manufacturer and authorized supplier of PYLARIFY®, necessitating this non-competitive procurement under the statutory authority of 41 U.S.C. 3304(a)(1). Interested parties are invited to submit capability statements or proposals within seven days of the notice's publication; otherwise, the contract will be awarded to Progenics without further notice. For inquiries, contact Contract Specialist Vance Farrell at vance.farrell@va.gov or call 210-694-6379.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Active
    Dept Of Defense
    The Department of Defense (DoD) is seeking quotations for pharmaceutical agents as part of the Uniform Formulary Blanket Purchase Agreement (UF BPA) and the Uniform Formulary Additional Discount Program (UF ADP) to support the Military Health System (MHS). This procurement is mandated by law to establish an effective pharmacy benefits program, which includes evaluating the clinical and cost-effectiveness of various pharmaceutical agents for inclusion in the DoD Uniform Formulary. The upcoming Pharmacy and Therapeutics (P&T) Committee meeting is scheduled for November 6-7, 2024, where newly approved drugs will be reviewed, and quotes are due by October 16, 2024. Interested parties should direct inquiries to Tracy Banks at tracy.e.banks2.civ@health.mil or Julia Trang at julia.n.trang.civ@health.mil for further details.
    PROCURMENT OF LEAD STYPHNATE AND TETRACENE M1-0080
    Active
    Dept Of Defense
    The Department of Defense, through the Naval Surface Warfare Center Indian Head Division (NSWC IHD), is seeking qualified small businesses to provide Normal Lead Styphnate and Tetracene as part of its Energetics program. The procurement involves the supply of 10 pounds of Normal Lead Styphnate and 5 pounds of Tetracene, adhering to strict military specifications for manufacturing, packaging, and delivery, including compliance with MIL-DTL-757C and MIL-T-46938 standards. This contract is crucial for ensuring the availability of high-quality energetic materials necessary for U.S. Navy and Joint Forces operations, reflecting the government's commitment to operational readiness and safety in explosive materials management. Interested parties must submit their quotes by October 15, 2024, at 4:00 PM EST, and can contact Latrice Whitfield at latrice.t.whitfield.civ@us.navy.mil for further information.
    Ruggedized Pressure Scanners
    Active
    Dept Of Defense
    The Department of Defense, specifically the Department of the Air Force, is seeking sources for ruggedized pressure scanners to replace existing systems at Arnold Air Force Base in Tennessee. The procurement aims to identify both small and large businesses capable of providing a commercial off-the-shelf (COTS) solution that meets specific technical requirements, including time-stamping capabilities and Ethernet communication with government systems. This initiative is crucial for upgrading the Air Force's ground test facilities to enhance operational efficiency and reliability. Interested vendors must submit their capabilities and relevant company information by 1:00 PM Central Time on October 16, 2024, to the primary contact, Haley Smith, at haley.smith.10@us.af.mil, with no funding allocated for preparation costs.
    Skyraider Parts and Maintenance
    Active
    Dept Of Defense
    The Defense Threat Reduction Agency (DTRA) is seeking qualified small business vendors to provide spare parts and maintenance services for the Teledyne FLIR R80 SkyRaider and Griffin G510 unmanned aerial systems. The procurement aims to ensure operational readiness and support for chemical, biological, radiological, and nuclear (CBRN) operations, requiring specialized equipment and maintenance capabilities. This initiative is critical for maintaining advanced defense technology to combat weapons of mass destruction, with specific tasks including D-level maintenance, software re-flashing, and timely delivery of spare parts. Interested vendors must submit their capabilities statements by 12:00 PM EST on October 8, 2024, to the primary contact, Terrie Overstreet, at terrie.l.overstreet.civ@mail.mil, with a courtesy copy to Russell Kelley at russell.v.kelley.civ@mail.mil.
    Pharmaceutical Preparation Manufacturing
    Active
    Dept Of Defense
    Sources Sought DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY is seeking local sources capable and interested in fulfilling a requirement for the procurement and delivery of CLASS VIII, Medical Laboratory Reagents, in support of United States Naval Hospital (USNH), located in Okinawa, Japan. The procurement is for ULTRA TECHNE KOW 18.5GBq Injection Generator, with an estimated quantity of 26 units per year. The delivery location will be the United States Naval Hospital (USNH) Okinawa Nuclear Medicine Department, Camp Foster, Okinawa, Japan. Interested parties should provide company information, capability to provide the items, and item lead times. Responses must be submitted by Thursday, November 09, 2023, via email to jasielle.castro@dla.mil and mamiko.jackson@dla.mil.
    Re-palletization and shipment
    Active
    Dept Of Defense
    The Department of Defense, specifically the Department of the Air Force, is seeking a contractor for the re-palletization and shipment of pallets currently located at Raytheon Technologies (RTX). The primary objective of this procurement is to repair these pallets and facilitate their shipment to a predetermined location, with the requirement to complete the shipment by April 1, 2025. This contract is critical as it involves the handling of guided missile components, underscoring the importance of maintaining operational readiness and supply chain integrity for defense operations. Interested parties must have access to RTX facilities and can contact Jesse Whinham at jesse.whinham@us.af.mil or 801-775-3237 for further details regarding this sole source Firm Fixed Price contract.
    Scott AFB Mobile Magnetic Resonance Imaging (MRI)
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) is soliciting quotes for Mobile Magnetic Resonance Imaging (MRI) services for the 375th Medical Group at Scott Air Force Base, Illinois, under Solicitation HT940724Q0008. The contract will cover a base period from October 15, 2024, to October 14, 2025, with options for two additional extensions, and aims to provide essential imaging services to support military operations. Compliance with industry standards, including HIPAA and CDC regulations, is critical, and contractors must ensure the provision of trained MRI technicians and a fully operational mobile unit. Interested vendors must submit their quotes electronically by 5 PM ET on October 4, 2024, and can direct inquiries to Contract Specialist Christopher Comish at christopher.j.comish.civ@health.mil or by phone at 210-952-8620.